Literature DB >> 32239201

Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma.

Dylan A Levy1, Hong Li2,3, Katherine R Sterba2,3, Chanita Hughes-Halbert3,4, Graham W Warren3,5,6, Brian Nussenbaum7, Anthony J Alberg8, Terry A Day1, Evan M Graboyes1,3.   

Abstract

Importance: The standard of care for initiation of postoperative radiotherapy (PORT) in head and neck squamous cell carcinoma (HNSCC) is within 6 weeks of surgical treatment. Delays in guideline-adherent PORT initiation are common, associated with mortality, and a measure of quality care, but patient-specific tools to estimate the risk of these delays are lacking. Objective: To develop and validate 2 nomograms (that use presurgical and postsurgical data) for predicting delayed PORT initiation. Design, Setting, and Participants: This cohort study obtained patient data from January 1, 2004, to December 31, 2015, from the National Cancer Database. Adults aged 18 years or older with a newly diagnosed HNSCC who underwent surgical treatment and PORT at a Commission on Cancer-accredited facility were included. Data analysis was conducted from June 2, 2019, to January 29, 2020. Exposures: Surgical treatment and PORT. Main Outcomes and Measures: The primary outcome measure was PORT initiation more than 6 weeks after the surgical intervention. Multivariable logistic regression models were created in a random selection of 80% of the sample (derivation cohort) and were internally validated with bootstrapping, assessed for discrimination by calibration plots and the concordance (C) index, and externally validated in the remaining 20% of the sample (validation cohort).
Results: The study included 60 766 adults with HNSCC who were grouped into derivation and validation cohorts. The derivation cohort comprised 48 625 patients (mean [SD] age, 59.59 [11.3] years; 36 825 men [75.7%]) selected randomly from the full sample, whereas 12 151 patients (mean [SD] age, 59.63 [11.2] years; 9266 men [76.3%]) composed the validation cohort. The rate of PORT delay was 55.8% (n=27140) in the derivation cohort and 56.7% (n=6900) in the validation cohort. Both nomograms created to predict the risk of PORT initiation delay used variables, including race/ethnicity, insurance type, tumor site, and facility type. The nomogram based on presurgical variables included clinical stage and severity of comorbidity, whereas the nomogram with postsurgical variables included US region, length of stay, and care fragmentation between surgical and radiotherapy facilities. For the presurgical nomogram, the concordance indices were 0.670 (95% CI, 0.664-0.676) in the derivation cohort and 0.674 (95% CI, 0.662-0.685) in the validation cohort. For the nomogram with postsurgical variables, the concordance indices were 0.691 (95% CI, 0.686-0.696) in the derivation cohort and 0.694 (95% CI, 0.685-0.704) in the validation cohort. Conclusions and Relevance: This study found that a nomogram developed with presurgical data to generate personalized estimates of PORT initiation delay may improve pretreatment counseling and the delivery of interventions to patients at high risk for such a delay. A nomogram including postsurgical data can drive institutional quality improvement initiatives and enhance risk-adjusted comparisons of delay rates across facilities.

Entities:  

Year:  2020        PMID: 32239201      PMCID: PMC7118672          DOI: 10.1001/jamaoto.2020.0222

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  25 in total

1.  Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.

Authors:  Carole Fakhry; Qiang Zhang; Phuc Felix Nguyen-Tân; David I Rosenthal; Randal S Weber; Louise Lambert; Andy M Trotti; William L Barrett; Wade L Thorstad; Christopher U Jones; Sue S Yom; Stuart J Wong; John A Ridge; Shyam S D Rao; James A Bonner; Eric Vigneault; David Raben; Mahesh R Kudrimoti; Jonathan Harris; Quynh-Thu Le; Maura L Gillison
Journal:  J Clin Oncol       Date:  2017-08-04       Impact factor: 44.544

Review 2.  Nomograms in oncology: more than meets the eye.

Authors:  Vinod P Balachandran; Mithat Gonen; J Joshua Smith; Ronald P DeMatteo
Journal:  Lancet Oncol       Date:  2015-04       Impact factor: 41.316

3.  The impact of treatment package time on locoregional control for HPV+ oropharyngeal squamous cell carcinoma treated with surgery and postoperative (chemo)radiation.

Authors:  Hann-Hsiang Chao; Caitlin A Schonewolf; Erik X Tan; Samuel Swisher-McClure; Alireza F Ghiam; Gregory S Weinstein; Bert W O'Malley; Ara A Chalian; Christopher H Rassekh; Jason G Newman; Roger B Cohen; Joshua M Bauml; Charu Aggarwal; Alexander Lin; John N Lukens
Journal:  Head Neck       Date:  2019-08-14       Impact factor: 3.147

4.  Defining Optimal Treatment Times in Head and Neck Cancer Care: What Are We Waiting For?

Authors:  Jeffrey J Houlton
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-02-01       Impact factor: 6.223

5.  Timely Adjuvant Postoperative Radiotherapy: Racing to a PORT in the Storm.

Authors:  Marita S Teng; Vishal Gupta
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-12-01       Impact factor: 6.223

6.  Postoperative radiation performed at the same surgical facility associated with improved overall survival in oral cavity squamous cell carcinoma.

Authors:  Arya Amini; William A Stokes; Bernard L Jones; Sagus Sampath; Robert S Kang; Thomas J Gernon; Ellie G Maghami; Erminia Massarelli; Cathy J Bradley; Sana D Karam
Journal:  Head Neck       Date:  2019-02-09       Impact factor: 3.147

7.  Quality and performance indicators in an academic department of head and neck surgery.

Authors:  Randal S Weber; Carol M Lewis; Scott D Eastman; Ehab Y Hanna; Olubumi Akiwumi; Amy C Hessel; Stephen Y Lai; Leslie Kian; Michael E Kupferman; Dianna B Roberts
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-12

8.  American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine.

Authors:  Michael W Kattan; Kenneth R Hess; Mahul B Amin; Ying Lu; Karl G M Moons; Jeffrey E Gershenwald; Phyllis A Gimotty; Justin H Guinney; Susan Halabi; Alexander J Lazar; Alyson L Mahar; Tushar Patel; Daniel J Sargent; Martin R Weiser; Carolyn Compton
Journal:  CA Cancer J Clin       Date:  2016-01-19       Impact factor: 508.702

9.  Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for laryngeal cancer.

Authors:  Warren C Swegal; Robert J Herbert; David W Eisele; Jenny Chang; Robert E Bristow; Christine G Gourin
Journal:  Laryngoscope       Date:  2019-06-06       Impact factor: 3.325

10.  Clinical Factors Associated With Reoperation and Prolonged Length of Stay in Free Tissue Transfer to Oncologic Head and Neck Defects.

Authors:  William W Thomas; Jason Brant; Jinbo Chen; Orly Coblens; John P Fischer; Jason G Newman; Ara A Chalian; Rabie M Shanti; Steven B Cannady
Journal:  JAMA Facial Plast Surg       Date:  2018-03-01       Impact factor: 4.611

View more
  8 in total

1.  Early Mortality among Patients with Head and Neck Cancer Diagnosed in Thuringia, Germany, between 1996 and 2016-A Population-Based Study.

Authors:  Mussab Kouka; Jens Buentzel; Holger Kaftan; Daniel Boeger; Andreas H Mueller; Andrea Wittig; Stefan Schultze-Mosgau; Thomas Ernst; Orlando Guntinas-Lichius
Journal:  Cancers (Basel)       Date:  2022-06-24       Impact factor: 6.575

2.  Nomogram prediction for the overall survival and cancer-specific survival of patients diagnosed with Merkel cell carcinoma.

Authors:  Xufeng Yin; Huihui She; Lorna Martin Kasyanju Carrero; Weiwei Ma; Bingrong Zhou
Journal:  Ann Transl Med       Date:  2021-02

3.  A nomogram for predicting postoperative pulmonary infection in esophageal cancer patients.

Authors:  Shuang Li; Jingwen Su; Qiyu Sui; Gongchao Wang
Journal:  BMC Pulm Med       Date:  2021-09-06       Impact factor: 3.317

Review 4.  An equity-based narrative review of barriers to timely postoperative radiation therapy for patients with head and neck squamous cell carcinoma.

Authors:  Elizabeth A Noyes; Ciersten A Burks; Andrew R Larson; Daniel G Deschler
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-11-09

5.  A Nomogram to Predict Regrowth After Ultrasound-Guided Radiofrequency Ablation for Benign Thyroid Nodules.

Authors:  Lin Yan; Mingbo Zhang; Xinyang Li; YingYing Li; Yukun Luo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-17       Impact factor: 5.555

6.  Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer.

Authors:  Evan M Graboyes; Katherine R Sterba; Hong Li; Graham W Warren; Anthony J Alberg; Elizabeth A Calhoun; Brian Nussenbaum; Jessica McCay; Courtney H Marsh; Nosayaba Osazuwa-Peters; David M Neskey; John M Kaczmar; Anand K Sharma; Jennifer Harper; Terry A Day; Chanita Hughes-Halbert
Journal:  JCO Oncol Pract       Date:  2021-03-10

7.  Head and neck cancer radiotherapy amid COVID-19 pandemic: Report from Milan, Italy.

Authors:  Daniela Alterio; Stefania Volpe; Giulia Marvaso; Irene Turturici; Annamaria Ferrari; Maria Cristina Leonardi; Roberta Lazzari; Massimo Sarra Fiore; Giammaria Bufi; Federica Cattani; Camilla Arrobbio; Filippo Patti; Alessia Casbarra; Iacopo Cavallo; Fabrizio Mastrilli; Roberto Orecchia; Barbara Alicja Jereczek-Fossa
Journal:  Head Neck       Date:  2020-06-18       Impact factor: 3.821

8.  Head and neck radiotherapy amid the COVID-19 pandemic: practice recommendations of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).

Authors:  Daniela Alterio; Stefania Volpe; Almalina Bacigalupo; Pierluigi Bonomo; Francesca De Felice; Francesco Dionisi; Ida D'Onofrio; Elisa D'Angelo; Alessia Di Rito; Giuseppe Fanetti; Pierfrancesco Franco; Marta Maddalo; Anna Merlotti; Francesco Micciché; Ester Orlandi; Fabiola Paiar; Stefano Ursino; Matteo Pepa; Renzo Corvò; Nadia Gisella Di Muzio; Stefano Maria Magrini; Elvio Russi; Giuseppe Sanguineti; Barbara Alicja Jereczek-Fossa; Vittorio Donato; Daniela Musio
Journal:  Med Oncol       Date:  2020-08-17       Impact factor: 3.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.